SEC Form 4 · accession 0001209191-18-062514
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ginger L Graham
Director
Period of report
Dec 11, 2018
Accepted (ET)
Dec 13, 2018 · 6:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 11, 2018 | M | 8,250 | $17.59 | A | 35,148 | I | Held by the Ginger L. Graham Revocable Trust |
| Common Stock | Dec 11, 2018 | M | 8,250 | $14.37 | A | 43,398 | I | Held by the Ginger L. Graham Revocable Trust |
| Common Stock | Dec 11, 2018 | M | 8,250 | $25.79 | A | 51,648 | I | Held by the Ginger L. Graham Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy) | $17.59 | Dec 11, 2018 | M | 8,250 | D | Jun 9, 2010 | Jun 9, 2019 | Common Stock | 8,250 | 0 | D |
| Director Stock Option (right to buy) | $14.37 | Dec 11, 2018 | M | 8,250 | D | Jun 11, 2011 | Jun 11, 2020 | Common Stock | 8,250 | 0 | D |
| Director Stock Option (right to buy) | $25.79 | Dec 11, 2018 | M | 8,250 | D | Jun 10, 2012 | Jun 10, 2021 | Common Stock | 8,250 | 0 | D |